Klimovsky Judith V 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Sep 2, 2022
Insider Transaction Report
Form 4
Klimovsky Judith V.
Director
Transactions
- Exercise/Conversion
Common Stock
2022-09-01+35,082→ 49,684 total
Footnotes (1)
- [F1]The Reporting Person was granted Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of BLCM common stock. The RSUs vest in full on September 1, 2023, the one-year anniversary of the grant date.